Fabry Cardiomyopathy: Identification of Early Myocardial Structural and Tissue Abnormalities Using Multiparametric MRI

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

June 15, 2021

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Fabry Disease
Interventions
DIAGNOSTIC_TEST

Cardiac MRI, ECG/Holter and Blood Biomarkers

Cardiac MRI including T1/T2 mapping, ECG and blood biomarker evaluation will be performed at baseline and follow-up

Trial Locations (1)

M5G 2C4

RECRUITING

University Health Network, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Vancouver General Hospital

OTHER

collaborator

The Cleveland Clinic

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Mayo Clinic

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

IRCCS Policlinico S. Donato

OTHER

collaborator

Alberta Health services

OTHER

collaborator

Libin Cardiovascular Institute of Alberta

OTHER

lead

University Health Network, Toronto

OTHER